pharma · HNSCC · Squamous Cell Carcinoma of the Skin · PHIO
Phio Pharmaceuticals
Phio Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
King of Prussia, USA HQ
2012 Founded
15 Employees
Public company Type
PHIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- King of Prussia, USA
- Founded
- 2012
- Employees
- 15
- Programs
- 2
- Drugs
- 0
- Patents
- 39
Phio Pharmaceuticals pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Phio Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.